Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs
The impact of institutions and regulations on the innovation process was assessed during this development process. These findings are expected to provide valuable insights into the innovation system for new modalities.
Authors
- Shintaro Sengoku (ORCID: https://orcid.org/0000-0001-8008-3667)
- Hiromu Yoshiura
- Y. Kawata
Institutions
- Tokyo Institute of Technology (JP)
Publication Details
- Journal
- Therapeutic Innovation & Regulatory Science
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1007/s43441-024-00701-x
- Citations
- 1
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.24
Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science